Retinal Eye - Medika Life

Retinal imaging is critical in the field of ophthalmology and provides a trove of information that enables physicians to visualize a disease and its...

Research Drives AMD Treatments Toward Targeted Therapies

Deborah Ferrington PhD - March 26, 2024

Age-related macular degeneration (AMD) is the leading cause of blindness for those 55 years and older.

Envisioning a Future with Reversal of Glaucoma-Related Vision Loss

Brian Francis - March 26, 2025

More than 4.2 million Americans live with glaucoma, or about 1.6% of the country’s adult population, and only half are aware they have the disease.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Treating Rare Diseases: The Challenge of Access

Envisioning a Future with Reversal of Glaucoma-Related Vision Loss

Research Drives AMD Treatments Toward Targeted Therapies

Revolutionizing Retinal Imaging: The Role of Artificial Intelligence

LATEST

TRENDING

Contact Lenses and Cancer: Is There a Connection?

Revolutionizing Retinal Imaging: The Role of Artificial Intelligence

Sleep May Be Associated with Eye Health

Research Drives AMD Treatments Toward Targeted Therapies

Vision and COVID-19

Envisioning a Future with Reversal of Glaucoma-Related Vision Loss

Treating Rare Diseases: The Challenge of Access

EDITORS CHOICE

Vision and COVID-19

Revolutionizing Retinal Imaging: The Role of Artificial Intelligence

Research Drives AMD Treatments Toward Targeted Therapies

Envisioning a Future with Reversal of Glaucoma-Related Vision Loss

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories